Gossamer Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	32.11	111.97	183.47	486.62	135.09	105.42	0.32	0.06
Short-Term Investments	264.32	143.71	141.82	26.57	266.74	123.44	0	0
Cash & Cash Equivalents	296.43	255.68	325.28	513.19	401.83	228.86	0.32	0.06
Cash Growth	15.94%	-21.40%	-36.62%	27.71%	75.58%	72553.33%	425.00%	-
Other Current Assets	10.09	6.2	6.5	9.13	7.49	3.1	0.13	0
Total Current Assets	306.52	261.88	331.78	522.32	409.32	231.95	0.45	0.06
Property, Plant & Equipment	4.78	9.89	10.8	16.08	15.73	3.19	0	0
Other Long-Term Assets	0.62	0.68	1.08	1.03	1.56	4.27	0	0
Total Long-Term Assets	5.4	10.57	11.88	17.11	17.29	7.47	0	0
Total Assets	311.92	272.45	343.66	539.43	426.6	239.42	0.45	0.06
Accounts Payable	5.53	1.46	3.24	7.51	0.96	2.18	0.1	0.04
Current Debt	11.61	11.61	0	0	0	0	0	0
Other Current Liabilities	34.46	36.16	36.62	31.14	35.97	18.22	1.17	0.1
Total Current Liabilities	51.6	49.23	39.86	38.65	36.92	20.4	1.27	0.14
Long-Term Debt	197.55	211.14	182.34	180.1	37.2	0	6.04	0.04
Other Long-Term Liabilities	0	0	0	0	0	0.72	0	0
Total Long-Term Liabilities	197.55	211.14	182.34	180.1	37.2	0.72	6.04	0.04
Total Liabilities	249.15	260.37	222.19	218.75	74.12	21.12	7.31	0.18
Total Debt	209.16	222.76	182.34	180.1	37.2	0	6.04	0.04
Debt Growth	-6.10%	22.17%	1.24%	384.19%	-	-	15000.00%	-
Retained Earnings	-1,212.04	-1,032.22	-811.53	-577.53	-334.17	-153.86	-6.89	-0.12
Comprehensive Income	-0.35	-0.57	0.05	0.6	0.26	-0.06	0	0
Shareholders' Equity	62.77	12.08	121.46	320.68	352.49	-120.07	-6.86	-0.12
Net Cash / Debt	87.26	32.92	142.95	333.09	364.63	228.86	-5.73	0.02
Net Cash / Debt Growth	165.06%	-76.97%	-57.09%	-8.65%	59.33%	-	-	-
Net Cash Per Share	0.57	0.39	1.91	4.86	6.66	35.18	-0.62	0.00
Working Capital	254.92	212.65	291.92	483.67	372.39	211.55	-0.82	-0.08
Book Value Per Share	0.41	0.14	1.62	4.68	6.44	-18.46	-0.75	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).